20 completed. 20 Phase 1.
By phase and status
Follow Nerandomilast: new trials by email Literature Review of Nerandomilast trials Research Report on Nerandomilast
Trials (filtered) newest first · largest first
All 20 trials
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|
A Study in Healthy Men to Test How Bosentan Influences the Amount of Nerandomilast in the Blood
Nerandomilast, Bosentan - Healthy | Phase 1 | Completed | 16 | 2025-08-26 | 2025-10-14 |
A Study in Healthy Men to Test Whether Carbamazepine Influences the Amount of Nerandomilast in the Blood
nerandomilast, carbamazepine - Healthy | Phase 1 | Completed | 16 | 2025-08-11 | 2025-10-14 |
A Study in Healthy People to Compare How 2 Different Low Dose Formulations of BI 1015550 Are Taken up in the Body
BI 1015550 - Healthy | Phase 1 | Completed | 64 | 2024-06-06 | 2025-12-01 |
A Study in Healthy People to Compare How 2 Different High Dose Formulations of BI 1015550 Are Taken up in the Body
Nerandomilast - Healthy | Phase 1 | Completed | 64 | 2024-06-04 | 2025-12-01 |
A Study in Healthy People to Test How BI 1015550 is Taken up in the Body When Given With or Without Food
BI 1015550 - Healthy | Phase 1 | Completed | 18 | 2024-05-28 | 2025-12-01 |
A Study in Healthy People to Test Whether Different Doses of BI 1015550 Have Potential to Induce Heart Rhythm Abnormalities
BI 1015550, Moxifloxacin, Placebo - Healthy | Phase 1 | Completed | 46 | 2024-03-06 | 2025-11-28 |
A Study to Test How Different Doses of Nerandomilast (BI 1015550) Are Taken up in the Body of Healthy Japanese Men
Nerandomilast - Healthy | Phase 1 | Completed | 12 | 2023-12-20 | 2025-12-01 |
A Study in Healthy Men to Test Whether BI 1015550 Influences the Amount of Nintedanib and Pirfenidone in the Blood
BI 1015550, Nintedanib, Pirfenidone - Healthy | Phase 1 | Completed | 14 | 2023-11-08 | 2025-12-02 |
A Study in Healthy Men to Test How BI 1015550 is Taken up and Handled by the Body
BI 1015550, BI 1015550 mixed with [C-14]-BI 1015550 - Healthy | Phase 1 | Completed | 8 | 2023-02-14 | 2025-11-28 |
A Study to Test How BI 1015550 is Taken up in the Blood of People With and Without Kidney Problems
BI 1015550 - Renal Insufficiency, Healthy | Phase 1 | Completed | 26 | 2023-02-09 | 2025-11-28 |
A Study to Test How BI 1015550 is Taken up in the Blood of People With and Without Liver Problems
BI 1015550 - Hepatic Insufficiency | Phase 1 | Completed | 28 | 2023-02-07 | 2025-11-28 |
A Study in Healthy Chinese People to Test How Different Doses of BI 1015550 Are Taken up in the Body
BI 1015550 - Healthy | Phase 1 | Completed | 24 | 2023-01-13 | 2025-11-28 |
A Study in Healthy Men to Test Whether BI 1015550 Influences the Amount of Midazolam in the Blood
BI 1015550, midazolam - Healthy | Phase 1 | Completed | 15 | 2022-10-11 | 2025-12-01 |
A Study in Healthy People to Compare 2 Different Formulations of BI 1015550 Taken With or Without Food
Reference (R), Test treatment 1 (T1), Test treatment 2 (T2) - Healthy | Phase 1 | Completed | 24 | 2022-08-15 | 2025-12-19 |
A Study in Healthy Men to Find Out How BI 1015550 is Taken up and Handled by the Body
BI 1015550 (C-14) - Healthy | Phase 1 | Completed | 6 | 2021-03-25 | 2025-11-28 |
This Study is Done in Healthy Japanese Volunteers. It Looks at How Different Doses of BI 1015550 Are Taken up in the Body and How Well They Are Tolerated.
BI 1015550 6 mg, Placebo - Healthy | Phase 1 | Completed | 16 | 2018-06-04 | 2025-11-28 |
This Study in Healthy Men Tests How Itraconazole Influences the Amount of BI 1015550 in the Blood
BI 1015550, itraconazole - Healthy | Phase 1 | Completed | 16 | 2018-05-03 | 2025-11-28 |
This Study Tests Different Doses of BI 1015550 in Patients With Idiopathic Pulmonary Fibrosis (IPF). The Study Tests How BI 1015550 is Taken up by the Body and How Well it is Tolerated.
BI 1015550, Placebo - Idiopathic Pulmonary Fibrosis | Phase 1 | Completed | 15 | 2018-03-16 | 2025-11-28 |
Relative Bioavailability of BI 1015550 Following Oral Administration Under Fed and Fasted Conditions in Healthy Male Subjects
BI 1015550 - Healthy | Phase 1 | Completed | 12 | 2017-10-16 | 2025-11-28 |
This Study Tests How Healthy Men Tolerate Different Doses of BI1015550. The Study Also Tests How BI 1015550 is Taken up by the Body
Placebo Single Dose (SD), BI 1015550 Single Dose (SD), Placebo Multiple Dose (MD) - Healthy | Phase 1 | Completed | 42 | 2017-08-10 | 2025-11-28 |
Conditions studied
Hepatic Insufficiency (1) · Idiopathic Pulmonary Fibrosis (1) · Renal Insufficiency (1)
Sponsors
Boehringer Ingelheim (20)
Countries
Germany (14) · Netherlands (3) · Japan (2) · United Kingdom (2) · China (1) · Denmark (1) · Finland (1) · Italy (1) · Spain (1)
Results publications
PMID 42563128
NIH funding
2017 (4), 2023 (4), 2025 (2)